Skip Nav Destination
Issues
1 December 2016
-
Cover Image
Cover Image
This cover micrograph shows the heatmap of probe intensity by histology of colorectal biopsy. The histologic groups of colorectal endoscopy biopsy included normal mucosa (NM), hyperplastic polyps (HP), tubular adenomas (TA), sessile serrated adenoma polyp (SSA/P), traditional serrated adenoma (TSA), and tubulovillous adenoma or villous adenoma with high-grade dysplasia (TVHG). Samples were grouped by histology and malignant potential as: HPNM (lowest), SSA and TA (low), TSA (high), and TVHG (highest). The risk classifications are based on criteria defined by the US Multi-Society Task Force on Colorectal Cancer. This heatmap shows the clustering of miRNA signatures by polyp histology. A total of 99 miRNAs were found to differ significantly across the five prespecified histologic types (i.e., mean signal intensities were significantly different in at least one histology group, FDR P < 0.05). See the article by Tsikitis and colleagues (beginning on page 942) for more information. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Minireview
Review
Research Articles
A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia
Stephen Lam; for the Cancer Prevention Network; Sumithra J. Mandrekar; for the Cancer Prevention Network; Yaron Gesthalter; for the Cancer Prevention Network; Katie L. Allen Ziegler; for the Cancer Prevention Network; Drew K. Seisler; for the Cancer Prevention Network; David E. Midthun; for the Cancer Prevention Network; Jenny T. Mao; for the Cancer Prevention Network; Marie Christine Aubry; for the Cancer Prevention Network; Annette McWilliams; for the Cancer Prevention Network; Don D. Sin; for the Cancer Prevention Network; Tawimas Shaipanich; for the Cancer Prevention Network; Gang Liu; for the Cancer Prevention Network; Evan Johnson; for the Cancer Prevention Network; Andrea Bild; for the Cancer Prevention Network; Marc E. Lenburg; for the Cancer Prevention Network; Diana N. Ionescu; for the Cancer Prevention Network; John Mayo; for the Cancer Prevention Network; Joanne (Eunhee) Yi; for the Cancer Prevention Network; Henry Tazelaar; for the Cancer Prevention Network; William S. Harmsen; for the Cancer Prevention Network; Judith Smith; for the Cancer Prevention Network; Avrum E. Spira; for the Cancer Prevention Network; Jennifer Beane; for the Cancer Prevention Network; Paul J. Limburg; for the Cancer Prevention Network; Eva Szabo; for the Cancer Prevention Network
Author Choice
Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes
Rafael Guerrero-Preston; Blanca L. Valle; Anne Jedlicka; Nitesh Turaga; Oluwasina Folawiyo; Francesca Pirini; Fahcina Lawson; Angelo Vergura; Maartje Noordhuis; Amanda Dziedzic; Gabriela Pérez; Marisa Renehan; Carolina Guerrero-Diaz; Edgar De Jesus Rodríguez; Teresa Diaz-Montes; José Rodríguez Orengo; Keimari Méndez; Josefina Romaguera; Bruce J. Trock; Liliana Florea; David Sidransky
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.